Reprogramming Macrophages to Drive Anti-Tumor Immunity
Time: 10:30 am
Details:
• Overview of macrophage reprogramming for cancer immunotherapy, including proprietary CAR-M technologies
• Preview of novel modalities, including in vivo macrophage reprogramming
